“pfizer” Archives

in
Entry Author Date Location
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
In The Eyes Of VCs, Saunders Will Be The “Pfizergan” Man 01/13/16 New York
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials 01/04/16 Boston
In Brooklyn, An Incubator Perseveres As Biotech Perks Up in the City 12/28/15 New York
Still Years From Clinic, Navitor Gets $33M And More Pharma Friends 12/18/15 Boston
Biogen, Arsia Team Up to Improve Hemophilia Drugs in $100M Pact 12/16/15 Boston
West Coast Biotech Roundup: Otonomy, Oncothyreon, Gilead, & More 12/14/15 San Diego
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Keeping Score, Clinical Watchdogs Push Drugmakers For More Open Data 11/17/15 National
Biogen Helps Put $42.5M Into a Father’s Duchenne Gene Therapy Quest 11/05/15 Boston
What’s Your DNA Worth? The Scramble To Cash In On the Genome 10/20/15 National
Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall 10/19/15 Boston
To Curb Brain Damage, Astrocyte Pharmaceuticals Energizes Cells 10/19/15 Texas
Raleigh-Durham Roundup: RTP Park Center, Liquidia, Novan, & More 10/06/15 Raleigh Durham
Bio Slump Hits IPOs as Edge, Mirna Cut Prices, Upsize to Close Deals 10/01/15 New York
Accelerator Adds $11.7M, Reels in AbbVie, WuxiTech to Back Startups 09/29/15 Seattle
With $75M, Deciphera Fuels Push For Cancer Drugs—And a Future IPO 09/21/15 Boston
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30 09/14/15 Boston
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
Loxo Oncology Appoints Esperion’s Mayleben to Board of Directors 08/10/15 Detroit Ann Arbor
Zoetis Gets Conditional License for Antibody Treatment of Itchy Dogs 08/05/15 Detroit Ann Arbor
vTv Therapeutics IPO Raises $117M For Alzheimer’s, Diabetes Drugs 07/30/15 Raleigh Durham
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Alzheimer’s Drug Firm vTv Therapeutics Sets Terms for $125M IPO 07/20/15 Raleigh Durham
Page 2 of 23 « previous page · next page »